Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

McMaster University

$150,000.00

Studies of the therapeutic benefits of targeting neutrophil extracellular trap (NET) components in a mouse model of sepsis

FY 2019-20

Summary
Sepsis is a type of blood poisoning that occurs when the body has an over reactive response to an infection. This can lead to tissue damage, organ failure, and death. Sepsis is recognized as a global health priority. The death rate from sepsis is high, suggesting that an improved understanding of how sepsis leads to death may develop into new therapies. Recently, it was discovered that high levels of free-floating DNA and histones in the blood can predict death in sepsis. This is likely released by white blood cells in response to trying to fight off the infection. In test tubes, free-floating DNA can trigger clotting in the blood. DNA often lives in blood together with histones. In test tubes, histones can kill blood vessels and make blood thicker. However, no one has confirmed that DNA and/or histones are harmful to mammals and contributes to death in sepsis. Some new studies show that getting rid of DNA with injections of DNase I minimally increases survival in mice. Other studies show that getting rid of histones with a treatment called heparin shows a small increase in survival in mice. Heparin is also a blood thinner and decreases inflammation. No one knows if these drugs used together can cure sepsis. Because both drugs on their own shows some survival improvement in sepsis, perhaps using them together will cure sepsis. This project has two objectives: (1) to find out if DNA and/or histones are just predictors of death or causes death and (2) if using a combination of DNase I and heparin can cure sepsis in a mouse model. As the Canadian population ages, sepsis is expected to continue to be a major contributor to mortality and an important health care issue. If we can find better therapies for sepsis, we will reduce the mortality and economic burden of sepsis.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
415889
Name
Medeiros Sarah K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Studies of the therapeutic benefits of targeting neutrophil extracellular trap (NET) components in a mouse model of sepsis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Blood; Dnase I; Hematology; Heparin; Physiology; Sepsis; Thrombosis; Treatment
Abstract
Sepsis is a type of blood poisoning that occurs when the body has an over reactive response to an infection. This can lead to tissue damage, organ failure, and death. Sepsis is recognized as a global health priority. The death rate from sepsis is high, suggesting that an improved understanding of how sepsis leads to death may develop into new therapies. Recently, it was discovered that high levels of free-floating DNA and histones in the blood can predict death in sepsis. This is likely released by white blood cells in response to trying to fight off the infection. In test tubes, free-floating DNA can trigger clotting in the blood. DNA often lives in blood together with histones. In test tubes, histones can kill blood vessels and make blood thicker. However, no one has confirmed that DNA and/or histones are harmful to mammals and contributes to death in sepsis. Some new studies show that getting rid of DNA with injections of DNase I minimally increases survival in mice. Other studies show that getting rid of histones with a treatment called heparin shows a small increase in survival in mice. Heparin is also a blood thinner and decreases inflammation. No one knows if these drugs used together can cure sepsis. Because both drugs on their own shows some survival improvement in sepsis, perhaps using them together will cure sepsis. This project has two objectives: (1) to find out if DNA and/or histones are just predictors of death or causes death and (2) if using a combination of DNase I and heparin can cure sepsis in a mouse model. As the Canadian population ages, sepsis is expected to continue to be a major contributor to mortality and an important health care issue. If we can find better therapies for sepsis, we will reduce the mortality and economic burden of sepsis.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Medeiros, Sarah K
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
McMaster University - $150,000 Grant (2019-20) | Canada Spends